Antiphospholipid syndrome (APS) is a systemic autoimmune disease characterized by
thrombotic or obstetric events occurring in individuals who have persistent antiphospholipid …

Several antiphospholipid antibody (aPL) profiles (“triple” and lupus anticoagulant [LA]
positivity) are associated with a higher risk for clinical manifestations of antiphospholipid …

Antiphospholipid syndrome (APS) is a systemic autoimmune disease characterized by
thrombotic and non-thrombotic macro-and microvascular manifestations and pregnancy …

Introduction The optimal secondary thromboprophylactic strategies for patients with
antiphospholipid syndrome (APS) and arterial thrombosis remain controversial. This study …

The antiphospholipid syndrome (APS) is an autoimmune disease characterized by the
presence of pathogenic antiphospholipid antibodies (aPL). Since approximately 30 years …

Antiphospholipid Patients Admitted in the Intensive Care Unit: What Must The Rheumatologist
Know? | Current Rheumatology Reports Skip to main content SpringerLink Account Menu Find …

Cognitive impairment is frequently reported among anti-phospholipid syndrome (APS)
patients as well as anti-phospholipid antibody (aPL) carriers, but it is less studied than other …

Objective The objective of this study was to explore what non-pharmacological interventions
have been examined for individuals with antiphospholipid syndrome (APS). Methods We …

The presence of antiphospholipid antibodies (aPLs) is associated with antiphospholipid
syndrome (APS), characterized by thrombosis and obstetric morbidity. aPLs included in APS …

Background Anti-β2GPI-domain I (β2GPI-DI) antibody is pathogenic in patients with
antiphospholipid syndrome (APS), but its additional clinical associations and diagnostic …